Penserra Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48K | Buy |
+1,676
| New | +$48K | ﹤0.01% | 767 |
|
|
2021
Q4 | – | Sell |
-885
| Closed | -$18K | – | 1401 |
|
|
2021
Q3 | $18K | Buy |
885
+30
| +4% | +$610 | ﹤0.01% | 1260 |
|
|
2021
Q2 | $16K | Buy |
855
+110
| +15% | +$2.06K | ﹤0.01% | 1196 |
|
|
2021
Q1 | $11K | Sell |
745
-10
| -1% | -$148 | ﹤0.01% | 1022 |
|
|
2020
Q4 | $10K | Buy |
+755
| New | +$10K | ﹤0.01% | 921 |
|